Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade.
Kobe C Yuen
,
Li-Fen Liu
,
Vinita Gupta
,
Shravan Madireddi
,
Shilpa Keerthivasan
,
Congfen Li
,
Deepali Rishipathak
,
Patrick Williams
,
Edward E Kadel
,
Hartmut Koeppen
,
Ying-Jiun Chen
,
Zora Modrusan
,
Jane L Grogan
,
Romain Banchereau
,
Ning Leng
,
AnnChristine Thastrom
,
Xiadong Shen
,
Kenji Hashimoto
,
Darren Tayama
,
Michiel S van der Heijden
,
Jonathan E Rosenberg
,
David F McDermott
,
Thomas Powles
,
Priti S Hegde
,
Mahrukh A Huseni
,
Sanjeev Mariathasan
More about this publication
Nature medicine
Volume
27
Issue nr.
3
Pages
560
Publication date
01-03-2021
Full text links
Publisher website (DOI)
10.1038/s41591-021-01246-4
Europe PubMed Central
33547461
Pubmed
33547461